TAK

#477
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.8500 USD
+0.08%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
17.8500
17.8500
Intervallo Annuale
12.9900
18.8950
Variazione giornaliera
+0.08%
Variazione Mensile
-1.44%
Variazione di 6 mesi
+25.84%
Variazione Annuale
+25.84%
Chiusura Precedente
17.8350
Apertura
17.8500
Bid
Ask
Minimo
17.8500
High
17.8500
Volume
1
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Notizie